Preprint
Article

Fetal Tele-Echocardiography – An Approach to Improving Diagnosis and Management

This version is not peer-reviewed.

Submitted:

15 October 2024

Posted:

15 October 2024

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract
Introduction: Antenatal diagnosis of cardiac abnormalities and counselling parents about postnatal care requires a multidisciplinary team which includes a paediatric cardiologist a neonatologist and a fetal medicine physician. Some of this expertise is not available in all centres with fetal medicine expertise, however with modern technology, this could be provided remotely. Our objective was to assess the feasibility and outcomes of a pre-natal multidisciplinary tele-echocardiography diagnostic and counselling services Materials and Methods: Two centres based in separate countries provided a joint diagnostic and counselling service over a period of 14 months. The primary centre undertook the fetal echocardiography with a Voluson E10 machine and images transmitted live using Zoom OPS system with video-consultation and counselling. The fetal echo was performed using the ISUOG Guidelines check list. Results: There was an initial feasibility period of 2 months during which 10 women whose fetuses had normal hearts were scanned to test the workability of the system. Over a period of 12 months, 513 high risk fetuses were then scanned and out of these 27 had congenital malformations. The most common were hypoplastic left heart syndrome (HHLS) and atrio-ventricular septal defect. Tele-echocardiography and counselling was successful in all the cases. Satisfaction with the service was 3.8/4 with the main limitation being the need for further referral to a tertiary centre for delivery. Conclusion: Tele-echocardiography is reliable and when combined with live counselling and support from a paediatric cardiologist, is an option acceptable to patients. The greatest benefit was from being counselled by a team of experts at a single consultation rather than having to travel to another centre for consultation. With rapidly evolving technology, making video transmission easier and less expensive, we feel that consideration should be given not only to the development of tele-echocardiography but extended to other aspects of fetal medicine.
Keywords: 
Subject: 
Medicine and Pharmacology  -   Obstetrics and Gynaecology

1. Introduction

Abnormalities of the heart are the most common congenital anomalies and the leading cause of perinatal mortality from congenital anomalies [1]. A study in Western Europe found that about 45% of infant deaths from congenital anomalies were secondary to congenital heart defects (CHD) [3]. Similarly, these contributed to 35%, 37%, 42% and 48% of deaths in Latin America, North America, Eastern Europe and the South Pacific regions respectively [3]. The prevalence of CHDs varies world-wide. In a population-based study in Northern England from 1998-2003 it was reported to be about 85.9/10,000 births and terminations, and 79.9/10,000 live births [4]. In Europe, data from EUROCAT (European Surveillance of Congenital Anomalies) the network of population-based registers of congenital anomalies in Europe, with a common protocol and data quality review, covering 1.5 million annual births in 22 countries, showed that CHDs were the most common non-chromosomal subgroup, at 65 per 10,000 births for the period 2003-2007 [5]. In the USA CHDs are the most common congenital anomaly occurring in about 100/10,000 life births and are responsible for 4.2% of all neonatal deaths [6,7].
Despite the fact that CHDs contribute to the highest perinatal mortality from congenital malformations, prenatal detection rates vary widely in different geographic regions and for various types of CHDs, with fewer than one half of cardiac anomalies being identified before birth [8–10]. Some variations can be attributed to differences in operator ability, transducer frequency, patient body habitus, abdominal scars, gestational age, amniotic fluid volume and fetal position [11–15]. In the UK for example the NHS Fetal Anomaly Screening Programme (FASP) sets a minimum standard detection rate of 50% for major cardiac abnormalities. Reported rates of prenatal diagnosis vary from 47-64% in the UK (47-59% for the period 2015-2016-in Norfolk [16] and 52 - 50.4% for the period 2021-22; in the UK overall [17]) to 71.5% [18] in Southern France. In the USA prenatal detection rates have risen from 23% nearly 20 years ago [19] to approximately 35% [20].
It is generally accepted that prenatal diagnosis can improve birth outcomes, particularly for certain types of CHDs. It allows for prenatal awareness of the specific CHD by clinicians who can plan management postnatally, parental education to allow preparation for the birth of a neonate that will require specialized care and services and the timing and place of delivery. Ideally such antenatal management should be provided by a multidisciplinary team consisting of a fetal medicine physician, a paediatric cardiologist, neonatologist, clinical geneticist and others (such as a cardiothoracic surgeon) where appropriate. There is robust evidence that such a set-up is associated with the best outcomes for fetuses diagnosed with CHDs in utero [21]. Such set-ups are limited to centres of excellence or university hospitals. However, a composite prenatal service is possible with the application of technology which is easily available. It is within this context that tele-ultrasonography has been shown to be extremely beneficial. Currently this approach is being used to screen for congenital malformations - some with real time imaging and others with transmission of recorded images/videos for review. In the context of CHD, there are limited studies where this technology has been used beyond that of diagnosis. In a study in the USA, there was evidence within New York that tele-echocardiography was not only useful in improving identification of CHDs but also in the provision of information to some of the women [22] We run a tertiary level diagnostic service in a private clinic where access to other expertise is unavailable on site. This means following diagnosis or suspicion of a congenital cardiac abnormality, the woman will have to be referred to a centre where multidisciplinary counselling can be provided. To overcome this, we set up a tele-echocardiography service with a paediatric cardiologist in a centre of excellence. Here we report on the feasibility of this setup, our experience over a period of 12 months and the feedback from the women using the service.

2. Subjects and Methods

Our centre is a tertiary level private fetal medicine centre manned by two sub-specialty trained fetal medicine physicians. There are two other obstetricians in the centre who refer patients to the fetal medicine specialist. The women attending the centre are either referred from other centres for a second opinion or attend primarily to receive most of their antenatal care. Some attend because of their history (diabetes, previous fetal abnormality or aneuploidy) for specialist ultrasound scan evaluation of the fetus. The throughput in the unit varies from 4500-5200 cases per year.

2.1. Set-up

The tele-echocardiography service was set-up in two phases. In the first phase (a pilot) which ran for two months, a total of 10 women who agreed to tele-echocardiography were scanned in the set-up primarily to test feasibility. This was undertaken to ensure that transmission was of the highest quality. The women were scanned with a GE Voluson E10 by one of two fetal medicine physicians [BA, or JCK]). The Tertiary Centre is based in Cairo where there is a Paediatric cardiologist (AE). Imaging is transmitted live to Cairo where the paediatric cardiologist (AE) sees the scanning, directs the acquisition of further planes (if necessary) and participates in the discussion and counselling with the on-site team and the patient. The standard approach to imaging the fetal heart (with a check list table) in our centre is that prescribed by ISUOG 2023 [15]. All the cases in this phase had normal hearts on imaging, hence there was no need for the cardiologist to communicate in detail with the patient’s other that reassuring them that all was normal. Once we had refined the transmission (i.e. ensured that there were no connectivity or network problems during transmission) and were happy with the two-way reviews’ discussions and conclusions, we then embarked on the 2nd phase of the programme.
The second phase included women with fetuses diagnosed with a CHD as well as some with suspected but unconfirmed cardiac abnormalities. The data we present are for a period of 12 months from April 2022 to March 2023

2.2. Details of Transmission Set up

Figure 1 shows the set-up at the centre where the scanning is performed and then transmitted to Cairo (the recipient centre with the Paediatric Cardiologist). A free application (OBS Studio 30.1.2) was downloaded onto a Laptop which was connected to the GE machine by and HDMI cable. The ZOOM was opened on the laptop and the screen shared to allow the Paediatric consultant to link into the consultation and view the scanning imagines which were also appearing on the laptop. As the application is free, and each session lasted no longer than 75 minutes, the ZOOM platform tended to be free as well.

2.3. Patient Satisfaction Survey

A patient satisfaction survey was undertaken for each of the women involved in the tele-echocardiography. The survey was based on a series of questions with answers rated on a 4-point Linkert scale (Table 1). For each of the variables (presented in the results) assessed, the woman was asked to score it based on the details in the Table 1. Various questions were used for the survey. These questions centred on the information provided about the setup, concerns about the involvement of an expert from a remote site in the imaging and discussions, including addressing concerns and answering all questions, the quality of information provided and the overall benefits of such a set-up. Each of the women was also asked about the option of being referred to the tertiary centre as opposed to having the tele-echocardiography service, as well as which aspect of the set-up they disliked most.
The cost savings were estimated by combining an approximate transport, consultation and echocardiography cost. There was no additional cost for the tele-echocardiography service although was this to be offered commercially the consultation from the paediatric cardiologist would be factored into the cost.

3. Results

Over a period of 12 months a total of 513 high risk fetuses were scanned for congenital heart disease in our center. A total of 4572 pregnant women were seen at our centre over this period. Of the 513 high risk cases who underwent fetal echography, 27 were diagnosed with congenital cardiac defects for an incidence of 5.3/100 or 53/10,000. Table 2 shows the demographics of these women. Values are presented as mean and range as the data were normally distributed. There were no differences in the demographics of mothers whose fetuses had a cardiac abnormality and those whose fetuses did not.
Table 3 shows the spectrum of abnormalities diagnosed. The most common were hypoplastic heart (8) and atrioventricular septal defect (7). There were two cases in which the diagnosis was modified by tele-echocardiography. These were initially classified as complex cardiac abnormalities but were later refined after specialist consultation.
Good quality images were obtained and transmitted to the cardiologist in all the cases. Counselling was jointly provided by the obstetrician and the paediatric cardiologist. The average time for each patient was 47 minutes (range 30 – 65 minutes). There were no technical issues encountered with transmission of the images and counselling of the couple.
Table 4 shows the survey results for the women. The overall score for this service was 3.8 out of 4. The aspect of the set-up that was least liked was the fact the women had to be referred to the tertiary hospital despite these multidisciplinary sessions. They would have preferred contacts with the team at the tertiary hospital at this set-up. Their anxiety was primarily because of fear of meeting new people and the possibility of being offered conflicting information and counselling. The quality and quantity of information provided was judged to be appropriate by everyone; they were all happy with the communication at these sessions. The time spent during the session was considered just adequate. The women, overall, felt very comfortable asking questions to the cardiologist although this was virtual. To most of them it was like have a video phone call with friends or family.
The estimated average cost savings for each woman that covered transport, consultation and echocardiography was USD749. Time off work to attend an additional assessment was not included in this estimate. The paediatric consultation cost was approximately USD200.

4. Discussion

Telehealth is defined as health actions carried out remotely, including consultation, diagnosis, therapeutic guidance, monitoring, and referral of patients [23,24]. It has been shown to be feasible and highly effective in fetal ultrasound examination and mostly in relation to linking rural areas with experts in centres of excellence [25–32]. Our set-up provides a virtual setting for multidisciplinary antenatal care for a highly specialised service.
In the context of fetal echocardiography, telemedicine offers an alternative referral strategy, whereby digitised images are transmitted electronically [33] with the potential to decrease time to diagnosis. In some cases, there is teleconsultation in real-time (where the sonographer scans and the remote specialist views the live images) [32,34,35] or via transmission of pre-recorded ultrasound images (store-and-forwarded) in the absence of the woman [36]. Stored-and-forwarded telemedicine has also been shown to be a reliable and acceptable first consultation for families with well recognised risk factors for CHD, and for women with screened with a suspected fetal heart anomaly [36]. Dowie et al. found no false-negative cardiac diagnoses and no significant differences in the antenatal mean costs until delivery for the cohort assessed by telemedicine compared with those referred for direct assessment [36].
The quality of the live transmissions in this set-up were just as good as face-to-face scanning. An additional benefit for the fetal medicine physicians was the help provided by the paediatric cardiologist in redefining the abnormalities through varied scanning planes and discussing the rationale for altering or refining the diagnosis. This was extremely beneficial to the fetal medicine physicians - it allowed for improvement in echocardiography techniques and furthermore, enabled appreciation of specific counselling on not only the diagnosis but the course of the abnormalities postpartum as well as their management. In fact, Fernandes et al. [37] concluded that a successful telemedicine program can also be beneficial to the professionals, the patients, and the health system itself.
In most of the cases the diagnosis was accurately made by the fetal medicine specialist. The paediatric cardiologist created a plan for immediate postnatal care. The type of intervention was discussed including interventional cardiac catheterisation or open - heart surgery. We have shown and confirmed that a complex prenatal service such as imaging and counselling for cardiac abnormalities by tele-echo is feasible. Such a setup could be replicated in other areas that are not fortunate enough to be able to provide combined on-site services. All patients were satisfied with the care received and valued the one-step approach for diagnosis and discussion of the plan of action after delivery.
Most previous fetal tele-echocardiography services concentrated on improving the diagnosis of congenital cardiac abnormalities (that has traditionally been low). In such set-ups images and/or videos are obtained by trained sonographers/obstetricians and transmitted to cardiologists/fetal medicine obstetricians for review. While these have consistently shown significantly higher detection rates for CHD, the women would invariably have to travel to centres of excellence for counselling. In a cost-effective analysis, Mistry and Gardiner [38] showed that providing tele-echo services were cost effective not only in high-risk cases but as a part of the antenatal anomaly service. In that particular set-up the involvement of a paediatric cardiologist made the counselling more effective.
Our set-up combines the confirmation of abnormalities, refining of diagnosis and counselling. The benefits of this approach are enormous as shown by the satisfactory score from the patients. Interestingly none of the women who were managed in this set-up had problems with the virtual counselling.
In a study in Kentucky, involving small regional hospitals and a paediatric referral centre a fetal tele-echo service was shown to be statistically associated with a significant increase in the rate of pre-natal diagnosis of CHD. This study concluded that fetal tele-echocardiography is an effective method that improves the rate of prenatal diagnosis in regions served by small regional hospitals with limited access to fetal echocardiography [22].
The technology used for this set-up is simple and should be possible in most units where there is WIFI with the adoption of teleconferencing platforms such as ZOOM. However, concerns must remain about ensuring confidentiality of such virtual consultation. The accuracy of this set up was in keeping with reported rates. Brown et al. [39] for example reported a specificity and a sensitivity of 100% for complex congenital heart disease, and a sensitivity of 100% and a specificity of 79% for the screening of less serious congenital heart diseases.
An important consideration in the provision of such a service is cost. For the women, there was a significant cost saving. Additional indirect costs not included were those of time off work for the additional service. In countries where there are costs associated with paediatric cardiologists working in tertiary paediatric cardiology units (or fetal medicine centres) some patients may struggle to meet the cost of such as service especially where there is no insurance cover. This could be compounded by travel cost - a factor that was not very crucial in our own cohort. Additional to this would be the wait to see the specialist which is associated with significant parental anxiety.

5. Limitations

While this set-up was highly valued and rated by the patients and the team involved in their care, one main limitation remained that these women had to be referred to a tertiary centre for their intrapartum and postnatal care. This meant undergoing further imaging to confirm our findings and followed again by counselling. Although this may seem a duplication, we feel that there are advantages to this - firstly the diagnosis had been confirmed by a paediatric cardiologist and it was therefore unlikely that this would be changed and secondly the parents would have already been prepared for the further counselling and management as this had already been offered in out set-up. A third limitation, though minor is the fact that our patients, going to the referral centre would have had to see a completely new team with its own problems. An ideal setting would be one involving the tertiary centre at the time of diagnosis where the delivery and postnatal care will be provided.
Another limitation was the fact that some of the patients had to make a second trip to our centre for this service following the diagnosis. An ideal set-up would be one where tele-echo multidisciplinary service is offered once the diagnosis is made or suspected. Logistically this was difficult to arrange but long-term we plan to run this clinic in tandem with the paediatric cardiologist so that all consultants will be contemporaneous.

6. Conclusions

We have been able to demonstrate the feasibility of a multidisciplinary tele-echocardiography diagnostic and counselling service with minimal need for additional resources. The benefits include more refined diagnosis, education for physicians at the primary site and benefits to the women in terms of counselling and preparing them for postnatal care (i.e. giving not only about the abnormality but on the postnatal treatment and course of the abnormality including its impact of quality of life). information to be provided at the centres where delivery will occur and allay any anxieties about diagnosis. Patient satisfaction was excellent; however, limitations included the need for a second visit for this consultation and the knowledge that further counselling by a new team would be provided at the centre of excellence where delivery and postnatal care will take place. We feel that this approach could be extrapolated to rare malformations with teams based on different continents, such as congenital diaphragmatic hernia and spina bifida where in-utero surgery is an option.

Author Contributions

Conception - Badredeen Ahmed and Justin C. Konje, Data Collection and analysis - Badreldeen Ahmed and Justin Konje, Set-up and acquisition of data - Amal Elsisi, Badreldeen Ahmed and Justin C Konje, Writing - First draft - Justin Konje. Revisions - Amal Elsisi and Badreldeen Ahmed. Approval of final version - Amal Elsisi, Badreldeen Ahmed and Justin C Konje.

Institutional Review Board Statement

Approval for the study was obtained from the Feto Maternal Centre Institutional Review Board (IRB Ref No of FMC/IRB/005/23rd March 2023.

Conflicts of Interest

No conflicts of interest to declare by any of authors.

References

  1. Bosi G. Congenital heart defects and disease: an epidemiological overview. Italian Journal of Pediatrics 2004; 30:261–266.
  2. Lee K, Khoshnood B, Chen L, Wall SN, Cromie WJ, Mittendorf RL. Infant mortality from congenital malformations in the United States, 1970–1997. Obstetrics and Gynecology 2001; 98:620–627.
  3. Botto LD, Correa A. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Progress in Pediatric Cardiology 2003; 18:111–121. [CrossRef]
  4. Dadvand P, Rankin J, Shirley MD, Rushton S, Pless-Mulloli T. Descriptive epidemiology of congenital heart disease in Northern England. Paediatr Perinat Epidemiol. 2009;23:58-65. [CrossRef]
  5. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349-64. [CrossRef] [PubMed]
  6. Triedman JK, Newburger JW. Trends in congenital heart disease. Circulation. 2016;133:2716-2733. [CrossRef]
  7. Centers for Disease Control and Prevention. Racial Differences by Gestational Age in Neonatal Deaths Attributable to Congenital Heart Defects --- United States, 2003--2006 [Internet]; 2010. [cited 2018 Dec 18] https://www.cdc.gov/mmwr/preview/mmwrhtml/mm 5937a3.htm?
  8. Liu Y, Chen S, Zuhlke L, Black GC, Choy MK, Li N, Keavney BD. Global birth prevalence of congenital heart defects 1970 – 2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48: 455–463. [CrossRef]
  9. Dolk H, Loane M, Garne E, European Surveillance of Congenital Anomalies Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123: 841–849.
  10. Quartermain MD, Pasquali SK, Hill KD, Goldberg DJ, Huhta JC, Jacobs JP, Jacobs ML, Kim S, Ungerleider RM. Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants. Pediatrics 2015; 136: e378–385. [CrossRef]
  11. Sharland GK, Allan LD. Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region. BJOG 1992; 99: 220–225.
  12. DeVore GR, Medearis AL, Bear MB, Horenstein J, Platt LD. Fetal echocardiogra- phy: factors that influence imaging of the fetal heart during the second trimester of pregnancy. J Ultrasound Med 1993; 12: 659–663.
  13. Tegnander E, Williams W, Johansen OJ, Blaas HG, Eik-Nes SH. Prenatal detection of heart defects in a non-selected population of 30,149 fetuses—detection rates and outcome. Ultrasound Obstet Gynecol 2006; 27: 252–265.
  14. van Nisselrooij AEL, Teunissen AKK, Clur SA, Rozendaal L, Pajkrt E, Linskens IH, Rammeloo L, van Lith JMM, Blom NA, Haak MC. Why are congenital heart defects being missed? Ultrasound Obstet Gynecol 2020; 55: 747–757.
  15. Carvalho JS, Axt-Fliedner R, Chaoui R, Copel JA, Cuneo BF, Goff D, Gordin Kopylov L, Hecher K, Lee W, Moon-Grady AJ, Mousa HA, Munoz H, Paladini D, Prefumo F, Quarello E, Rychik J, Tutschek B, Wiechec M, Yagel S. ISUOG Practice Guidelines (updated): fetal cardiac screening. Ultrasound Obstet Gynecol 2023; 61: 788–803. [CrossRef]
  16. Uzun O, Kennedy J, Davies C, Goodwin A, Thomas N, Rich D, Thomas A, Tucker D, Beattie B, Lewis MJ. Training: improving antenatal detection and outcomes of congenital heart disease. BMJ Open Qual. 2018;7:e000276. [CrossRef] [PubMed] [PubMed Central]
  17. https://www.nicor.org.uk/wp-content/uploads/2023/06/10633-NICOR-Annual-Summary_Reports_NCHDA_domain_Report_v7.pdf Accessed 19th June 2023.
  18. Suard C, Flori A, Paoli F, Loundou A, Fouilloux V, Sigaudy S, Michel F, Antomarchi J, Moceri P, Paquis-Flucklinger V, D'Ercole C, Bretelle F. Accuracy of prenatal screening for congenital heart disease in population: A retrospective study in Southern France. PLoS One. 2020;15:e0239476. [CrossRef] [PubMed] [PubMed Central]
  19. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 1999;354:1242-1247. [CrossRef]
  20. Current Cardiac Audit Database. Antenatal diagnosis. See http://wwww.ccad.org.uk/002/congenital.nsh/vwcontent. Antenatal%20Diagnosis?Opendocument (last checked 15 July 2012).
  21. Qiu X, Weng Z, Liu M, Chen X, Wu Q, Ling W, Ma H, Huang H, Lin Y. Prenatal diagnosis and pregnancy outcomes of 1492 fetuses with congenital heart disease: role of multidisciplinary-joint consultation in prenatal diagnosis. Sci Rep. 2020 ;10:7564. [CrossRef] [PubMed] [PubMed Central]
  22. Meiman J Zhang C, Holland B. Use of fetal tele-echo at small regional hospitals increases the rate of prenatal diagnosis of congenital heart disease. Prenatal Diagnosis 2021 Prenatal Diagnosis. 2022;42:1120–1132.
  23. Barbosa W, Zhou K, Waddell E, Myers T, Dorsey ER. Improving Access to Care: Telemedicine Across Medical Domains. Annu Rev Public Health. 2021;42:463–81. [CrossRef]
  24. Telemedicine solutions for clinical care delivery during COVID. -19 pandemic: A scoping review - PMC [Internet]. [citado 19 deagosto de 2022]. Recuperado de: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC9354887/.
  25. ChanFY,WhitehallJ,HayesL,TaylorA,SoongB,LessingK, et al. Minimum requirements for remote realtime fetal tele- ultrasound consultation. J Telemed Telecare 1999;5:171-6. [CrossRef]
  26. Fisk NM, Bower S, Sepulveda W, Garner P, Cameron K, Matthews M, et al. Fetal telemedicine: interactive transfer of realtime ultrasound and video via ISDN for remote consulta- tion. J Telemed Telecare 1995;1:38-44.
  27. ChanFY,SoongB,LessingK,WatsonD,CincottaR,BakerS, et al. Clinical value of real time tertiary fetal ultrasound con- sultation by telemedicine: preliminary evaluation. Telemed J 2000;6:237-42.
  28. Landwehr JB Jr, Zador IE, Wolfe HM, Dombrowski MP, Treadwell MC. Telemedicine and fetal ultrasonography: as- sessment of technical performance and clinical feasibility. Am J Obstet Gynecol 1997;177:846-8.
  29. Malone FD, Athanassiou A, Nores J, D’Alton ME. Effect of ISDN bandwidth on image quality for telemedicine transmis- sion of obstetric ultrasonography. Telemed J 1998;4:161-5.
  30. Wootton R, Dornan J, Fisk NM, Harper A, Barry-Kinsall C, Kyle P, et al. The effect of transmission bandwidth on diag- nostic accuracy in remote fetal ultrasound scanning. J Telemed Telecare 1997;3:209-14.
  31. Fisk NM, Sepulveda W, Drysdale K, Ridley D, Garner P, Bower S, et al. Fetal telemedicine: six month pilot of real-time ultrasound and video consultation between the Isle of Wight and London. Br J Obstet Gynaecol 1996;103:1092-5. [CrossRef]
  32. Darkins A, Fisk N, Garner P, Wootton R. Point-to-point telemedicine using the ISDN. J Telemed Telecare 1996;2 (Suppl 1):82-3.
  33. Begg L, Chan FY, Edie G, Hockey R, Wootton R. Minimum acceptable standards for digital compression of a fetal ultrasound video-clip.J Telemed Telecare 2001;7(Suppl. 2):88–90. [CrossRef]
  34. Chan FY, Soong B, Watson D, Whitehall J. Realtime fetal ultrasound by telemedicine in Queensland. A successful venture? J Telemed Telecare 2001;7(Suppl. 2):7 – 11. [CrossRef]
  35. Sharma S, Parness IA, Kamenir SA, et al. Screening fetal echocardiography by telemedicine: efficacy and community acceptance. J Am Soc Echocardiogr 2003;16:202–8. [CrossRef]
  36. Dowie R, Mistry H, Young TA, Franklin RC, Gardiner HM. Cost implications of introducing a telecardiology service to support fetal ultrasound screening. J Telemed Telecare 2008;14:421–6.
  37. Fernandes BA, Alves B, ·Matosinhos AC, · Calácio e Silva BL , Dias R, Hasparyk UG, Damásio J, Bastos FM, Simões e Silva AC. The use and role of telemedicine in maternal fetal medicine around the world: an up-to-date Health and Technology (2023) 13:365–372 . [CrossRef]
  38. Mistry H, Gardiner HM. The cost-effectiveness of prenatal detec- tion for congenital heart disease using telemedicine screening. J Telemed Telecare. 2013;19:190–. [CrossRef]
  39. Brown J, Holland B. Successful fetal Tele-Echo at a small Regional Hospital. Telemed J E-Health Off J Am Telemed Assoc. 2017;23:485–92. [CrossRef]
Figure 1. Set up for imaging and tele-counselling. In this picture, the Paediatric Cardiologist has been replaced with an ultrasound image.
Figure 1. Set up for imaging and tele-counselling. In this picture, the Paediatric Cardiologist has been replaced with an ultrasound image.
Preprints 121320 g001
Table 1. 4-point Linkert scale.
Table 1. 4-point Linkert scale.
Point Scale range Interpretation (with regards to experience
4 4.00-3.00 Excellent service (no negatives on the service)
3 2.99-2.00 Good service (one negative on the service)
2 1.99-1.00 Average service (2-3 negatives on the service
1 1.00-0.99 Poor service (>3 negatives on the service)
Table 2. Patient demography.
Table 2. Patient demography.
Variable Congenital cardiac* abnormality (N=27) Normal heart (N=486)*
Age (years) 33 (26-43) 29 (23-44)
BMI 26.8 (19.5-45.8) 25.8 (19.6-50.6)
Gravidity 4 (1-11) 3 (1-12)
GA at imaging 21 (19-24_ 19 (18-22)
GA = gestational age. BMI = body mass index. * P>0.05. for all the variables when the two groups are compared.
Table 3. Spectrum of congenital heart abnormalities over the period.
Table 3. Spectrum of congenital heart abnormalities over the period.
Congenital malformation No (%)
Hypoplastic left heart syndrome 8 (29.6)
Atrioventricular septal defect?? 7 (25.9)
Ventricular septal defects 4 (14.8)
Tricuspid atresia 3 (11.1)
Transposition of the great arteries (TGA) 3 (11.1)
Complex cardiac abnormalities 2 (7.4)
Table 4. Mean score from patient survey (scale of 1-4).
Table 4. Mean score from patient survey (scale of 1-4).
Variable Score obtained out of 4
Comfort with the set up 3.6
Communication of findings 3.8
Amount of information received at counselling 3.9
Understanding video counselling 3.5
Time to teleconsultation 3.4
Willingness of cardiologist to answer questions 3.8
Comfortable talking to the cardiologist virtually 3.7
Overall rating of the set-up and service 3.8
*Would you have preferred referring to tertiary centre for the consultation 1.2
Aspects that disliked most
• Waiting for the appointment
• Knowing that I will have to go and meet another team (in the hospital) to look after the baby
2.8
1.3
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2025 MDPI (Basel, Switzerland) unless otherwise stated